CN102264715A - 用于制备hcv的大环蛋白酶抑制剂的方法及中间体 - Google Patents
用于制备hcv的大环蛋白酶抑制剂的方法及中间体 Download PDFInfo
- Publication number
- CN102264715A CN102264715A CN2009801528515A CN200980152851A CN102264715A CN 102264715 A CN102264715 A CN 102264715A CN 2009801528515 A CN2009801528515 A CN 2009801528515A CN 200980152851 A CN200980152851 A CN 200980152851A CN 102264715 A CN102264715 A CN 102264715A
- Authority
- CN
- China
- Prior art keywords
- solvent
- salt
- mixture
- cinchonidune
- xxa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *[C@](C1)[C@](*)CC1=O Chemical compound *[C@](C1)[C@](*)CC1=O 0.000 description 3
- AHDSHKWSQYNLOU-PTSMCYBESA-N C=CC1C(CC2)CC([C@@H](c3cccc4c3cccc4)O)N2C1 Chemical compound C=CC1C(CC2)CC([C@@H](c3cccc4c3cccc4)O)N2C1 AHDSHKWSQYNLOU-PTSMCYBESA-N 0.000 description 1
- ZFBRXVPOWIZSHD-KUCUZAICSA-N Cc1c[s]c(-c2cc(O[C@H](C[C@H]3C(N[C@](C4)([C@@H]4/C=C\CCCCN4C)C(NS(C5CC5)(=O)=O)=O)=O)C[C@H]3C4=O)c(ccc(OC)c3C)c3n2)n1 Chemical compound Cc1c[s]c(-c2cc(O[C@H](C[C@H]3C(N[C@](C4)([C@@H]4/C=C\CCCCN4C)C(NS(C5CC5)(=O)=O)=O)=O)C[C@H]3C4=O)c(ccc(OC)c3C)c3n2)n1 ZFBRXVPOWIZSHD-KUCUZAICSA-N 0.000 description 1
- YWHQIVJPIBHBSV-UHFFFAOYSA-N OC(C(CC(C1)O2)C1C2=O)=O Chemical compound OC(C(CC(C1)O2)C1C2=O)=O YWHQIVJPIBHBSV-UHFFFAOYSA-N 0.000 description 1
- ULCJVOYMHWSZKZ-UHFFFAOYSA-N OC(C1C(C2)C3OC3[O-]C2C1)=O Chemical compound OC(C1C(C2)C3OC3[O-]C2C1)=O ULCJVOYMHWSZKZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/475—Preparation of carboxylic acid esters by splitting of carbon-to-carbon bonds and redistribution, e.g. disproportionation or migration of groups between different molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Furan Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08172691 | 2008-12-23 | ||
EP08172691.1 | 2008-12-23 | ||
PCT/EP2009/067715 WO2010072742A1 (en) | 2008-12-23 | 2009-12-22 | Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102264715A true CN102264715A (zh) | 2011-11-30 |
CN102264715B CN102264715B (zh) | 2015-12-02 |
Family
ID=40548041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200980152851.5A Expired - Fee Related CN102264715B (zh) | 2008-12-23 | 2009-12-22 | 用于制备hcv的大环蛋白酶抑制剂的方法及中间体 |
Country Status (23)
Country | Link |
---|---|
US (2) | US8927722B2 (zh) |
EP (1) | EP2382198B1 (zh) |
JP (1) | JP5687631B2 (zh) |
KR (1) | KR101734507B1 (zh) |
CN (1) | CN102264715B (zh) |
AR (1) | AR074863A1 (zh) |
AU (1) | AU2009331530B2 (zh) |
BR (1) | BRPI0923393B1 (zh) |
CA (1) | CA2745565C (zh) |
CY (1) | CY1114488T1 (zh) |
DK (1) | DK2382198T3 (zh) |
ES (1) | ES2429013T3 (zh) |
HK (1) | HK1164839A1 (zh) |
HR (1) | HRP20130906T1 (zh) |
IL (1) | IL213246A (zh) |
MX (1) | MX2011006764A (zh) |
PL (1) | PL2382198T3 (zh) |
PT (1) | PT2382198E (zh) |
RU (1) | RU2016120007A (zh) |
SI (1) | SI2382198T1 (zh) |
SM (1) | SMT201300116B (zh) |
TW (1) | TWI461424B (zh) |
WO (1) | WO2010072742A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105308043A (zh) * | 2014-05-29 | 2016-02-03 | 杭州普晒医药科技有限公司 | 丙型肝炎药物的晶型及其制备方法、其药物组合物和用途 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2382198T1 (sl) | 2008-12-23 | 2013-11-29 | Janssen Pharmaceuticals, Inc. | Postopek in vmesne spojine za pripravo makrocikličnega inhibitorja HCV proteaze |
AU2012311461B2 (en) * | 2011-09-22 | 2017-07-06 | Janssen Pharmaceuticals, Inc. | Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV |
BR112014009849A2 (pt) | 2011-10-28 | 2016-07-05 | Janssen Pharmaceuticals Inc | processo melhorado para preparação de intermediário do inibidor de protease macrocíclico tmc 435 |
CN103387509B (zh) * | 2012-05-11 | 2016-06-08 | 重庆博腾制药科技股份有限公司 | 一种hcv蛋白酶抑制剂中间体的制备方法 |
JP6209601B2 (ja) | 2012-06-08 | 2017-10-04 | ギリアード サイエンシーズ, インコーポレイテッド | フラビウイルス科ウイルスの大環状阻害剤 |
AR091279A1 (es) * | 2012-06-08 | 2015-01-21 | Gilead Sciences Inc | Inhibidores macrociclicos de virus flaviviridae |
ES2656087T3 (es) * | 2012-06-08 | 2018-02-23 | Gilead Sciences, Inc. | Inhibidores macrocíclicos de virus Flaviviridae |
UA119315C2 (uk) | 2012-07-03 | 2019-06-10 | Гіліад Фармассет Елелсі | Інгібітори вірусу гепатиту с |
ES2735355T3 (es) | 2013-03-15 | 2019-12-18 | Gilead Sciences Inc | Inhibidores macrocíclicos y bicíclicos de virus de hepatitis C |
MA41812A (fr) | 2015-03-27 | 2018-01-30 | Janssen Pharmaceuticals Inc | Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005073195A2 (en) * | 2004-01-30 | 2005-08-11 | Medivir Ab | Hcv ns-3 serine protease inhibitors |
CN101146794A (zh) * | 2005-01-21 | 2008-03-19 | 阿斯泰克斯治疗有限公司 | 用于抑制cdk和gsk的吡唑衍生物 |
WO2008092955A1 (en) * | 2007-02-01 | 2008-08-07 | Tibotec Pharmaceuticals Ltd. | Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8300536A (nl) | 1983-02-14 | 1984-09-03 | Oce Andeno Bv | Optisch actief alfa-azido-p-hydroxyfenylazijnzuur en zijn zouten alsmede de bereiding daarvan. |
JPS6124539A (ja) | 1984-07-11 | 1986-02-03 | Sagami Chem Res Center | 光学活性(r)−2,5,12−トリヒドロキシ−1,2,3,4−テトラヒドロナフタセン−6,11−ジオン−2−カルボン酸の取得方法 |
JP4218040B2 (ja) | 1997-12-26 | 2009-02-04 | 曽田香料株式会社 | 有機酸とアミンの複合塩の製造法 |
JP3844112B2 (ja) | 2000-08-23 | 2006-11-08 | 高砂香料工業株式会社 | 3,5,6−トリヒドロキシヘキサン酸アンモニウム塩誘導体、及びその製造方法 |
PE20070211A1 (es) | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
PL1919904T3 (pl) * | 2005-07-29 | 2014-06-30 | Janssen R&D Ireland | Makrocykliczne inhibitory wirusa zapalenia wątroby typu C |
JP5554570B2 (ja) * | 2007-02-08 | 2014-07-23 | ヤンセン・アールアンドデイ・アイルランド | Hcv阻害大環状フェニルカルバメート |
SI2382198T1 (sl) | 2008-12-23 | 2013-11-29 | Janssen Pharmaceuticals, Inc. | Postopek in vmesne spojine za pripravo makrocikličnega inhibitorja HCV proteaze |
-
2009
- 2009-12-22 SI SI200930731T patent/SI2382198T1/sl unknown
- 2009-12-22 JP JP2011541509A patent/JP5687631B2/ja not_active Expired - Fee Related
- 2009-12-22 CN CN200980152851.5A patent/CN102264715B/zh not_active Expired - Fee Related
- 2009-12-22 US US13/141,715 patent/US8927722B2/en not_active Expired - Fee Related
- 2009-12-22 PT PT09801447T patent/PT2382198E/pt unknown
- 2009-12-22 KR KR1020117017333A patent/KR101734507B1/ko active IP Right Grant
- 2009-12-22 DK DK09801447.5T patent/DK2382198T3/da active
- 2009-12-22 AR ARP090105059 patent/AR074863A1/es unknown
- 2009-12-22 MX MX2011006764A patent/MX2011006764A/es active IP Right Grant
- 2009-12-22 AU AU2009331530A patent/AU2009331530B2/en not_active Ceased
- 2009-12-22 EP EP09801447.5A patent/EP2382198B1/en active Active
- 2009-12-22 TW TW98144049A patent/TWI461424B/zh not_active IP Right Cessation
- 2009-12-22 PL PL09801447T patent/PL2382198T3/pl unknown
- 2009-12-22 BR BRPI0923393-8A patent/BRPI0923393B1/pt not_active IP Right Cessation
- 2009-12-22 ES ES09801447T patent/ES2429013T3/es active Active
- 2009-12-22 WO PCT/EP2009/067715 patent/WO2010072742A1/en active Application Filing
- 2009-12-22 CA CA2745565A patent/CA2745565C/en not_active Expired - Fee Related
- 2009-12-22 RU RU2016120007A patent/RU2016120007A/ru not_active Application Discontinuation
-
2011
- 2011-05-31 IL IL213246A patent/IL213246A/en not_active IP Right Cessation
-
2012
- 2012-05-29 HK HK12105238.7A patent/HK1164839A1/zh not_active IP Right Cessation
-
2013
- 2013-09-24 HR HRP20130906AT patent/HRP20130906T1/hr unknown
- 2013-10-10 CY CY20131100890T patent/CY1114488T1/el unknown
- 2013-10-10 SM SM201300116T patent/SMT201300116B/xx unknown
-
2014
- 2014-11-25 US US14/552,550 patent/US9115077B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005073195A2 (en) * | 2004-01-30 | 2005-08-11 | Medivir Ab | Hcv ns-3 serine protease inhibitors |
CN101146794A (zh) * | 2005-01-21 | 2008-03-19 | 阿斯泰克斯治疗有限公司 | 用于抑制cdk和gsk的吡唑衍生物 |
WO2008092955A1 (en) * | 2007-02-01 | 2008-08-07 | Tibotec Pharmaceuticals Ltd. | Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
Non-Patent Citations (2)
Title |
---|
ASA ROSENQUIST,等: "Synthesis of Enantionmerically Pure trans-3,4-Substituted Cyclopentanols by Enzymatic Resolution", 《ACTA CHEMICA SCANDINAVICA》 * |
周朝晖,等: "辛可尼丁上奎宁环的化学修饰", 《厦门大学学报(自然科学版)》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105308043A (zh) * | 2014-05-29 | 2016-02-03 | 杭州普晒医药科技有限公司 | 丙型肝炎药物的晶型及其制备方法、其药物组合物和用途 |
CN105308043B (zh) * | 2014-05-29 | 2018-01-30 | 杭州普晒医药科技有限公司 | 丙型肝炎药物的晶型及其制备方法、其药物组合物和用途 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102264715B (zh) | 用于制备hcv的大环蛋白酶抑制剂的方法及中间体 | |
KR101598135B1 (ko) | Hcv의 마크로사이클릭 프로테아제 억제제의 제조 방법 및 중간체 | |
JP2016164143A (ja) | Hcvの大環状プロテアーゼ阻害剤の製造のための方法及び中間体 | |
TWI565704B (zh) | 用於製備hcv巨環蛋白酶抑制劑之方法及中間物 | |
RU2588132C2 (ru) | Способы и промежуточные соединения для получения макроциклического ингибитора протеазы вируса гепатита с | |
KR20100024747A (ko) | 디엘-무스콘의 신규 합성중간체 및 디-무스콘과 엘-무스콘의 분리 정제방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1164839 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: new jersey Patentee after: Ortho-Mcneil-Janssen Pharmaceuticals Inc Address before: new jersey Patentee before: Ortho Mcneil Janssen Pharm |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1164839 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151202 Termination date: 20181222 |